Zhang D - Search Results

1

Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator.

Luo G, Lin X, Li Z, Xiao M, Li X, Zhang D, Xiang H. Luo G, et al. Among authors: zhang d. Eur J Med Chem. 2021 Jan 1;209:112910. doi: 10.1016/j.ejmech.2020.112910. Epub 2020 Oct 7. Eur J Med Chem. 2021. PMID: 33049605

2

[Synthesis and bioactivity of 2-arylimino-4-thiazolidones].

Zhang DY, Xiang H, Xu YG, Hua WY. Zhang DY, et al. Yao Xue Xue Bao. 2006 Sep;41(9):825-9. Yao Xue Xue Bao. 2006. PMID: 17111827 Chinese.

3

Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.

Zeng YF, Wu JQ, Shi LY, Wang K, Zhou B, Tang Y, Zhang DY, Wu YC, Hua WY, Wu XM. Zeng YF, et al. Bioorg Med Chem Lett. 2012 Mar 1;22(5):1922-5. doi: 10.1016/j.bmcl.2012.01.051. Epub 2012 Jan 26. Bioorg Med Chem Lett. 2012. PMID: 22318158

4

Synthesis of new ent-labdane diterpene derivatives from andrographolide and evaluation on cytotoxic activities.

Luo Y, Wang K, Zhang MH, Zhang DY, Wu YC, Wu XM, Hua WY. Luo Y, et al. Bioorg Med Chem Lett. 2015 Jun 1;25(11):2421-4. doi: 10.1016/j.bmcl.2015.03.086. Epub 2015 Apr 4. Bioorg Med Chem Lett. 2015. PMID: 25913115

5

Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents.

Zou Y, Yan C, Zhang H, Xu J, Zhang D, Huang Z, Zhang Y. Zou Y, et al. Among authors: zhang d, zhang h, zhang y. Eur J Med Chem. 2017 Sep 29;138:313-319. doi: 10.1016/j.ejmech.2017.06.046. Epub 2017 Jun 27. Eur J Med Chem. 2017. PMID: 28686911

6

Recent progress of sodium-glucose transporter 2 inhibitors as potential antidiabetic agents.

Zhang Y, Ban H, Yu R, Wang Z, Zhang D. Zhang Y, et al. Among authors: zhang d. Future Med Chem. 2018 May 1;10(10):1261-1276. doi: 10.4155/fmc-2017-0241. Epub 2018 May 11. Future Med Chem. 2018. PMID: 29749749 Review.

7

Diterpenoid lead stevioside and its hydrolysis products steviol and isosteviol: Biological activity and structural modification.

Wang M, Li H, Xu F, Gao X, Li J, Xu S, Zhang D, Wu X, Xu J, Hua H, Li D. Wang M, et al. Among authors: zhang d. Eur J Med Chem. 2018 Aug 5;156:885-906. doi: 10.1016/j.ejmech.2018.07.052. Epub 2018 Jul 24. Eur J Med Chem. 2018. PMID: 30059803 Review.

8

Structure-based design and synthesis of 1H-pyrazolo[3,4-d]pyrimidin-4-amino derivatives as Janus kinase 3 inhibitors.

Yin Y, Chen CJ, Yu RN, Wang ZJ, Zhang TT, Zhang DY. Yin Y, et al. Bioorg Med Chem. 2018 Sep 15;26(17):4774-4786. doi: 10.1016/j.bmc.2018.04.005. Epub 2018 Apr 4. Bioorg Med Chem. 2018. PMID: 30139575

9

Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold.

Yin Y, Chen CJ, Yu RN, Shu L, Zhang TT, Zhang DY. Yin Y, et al. Bioorg Med Chem. 2019 Apr 15;27(8):1562-1576. doi: 10.1016/j.bmc.2019.02.054. Epub 2019 Feb 28. Bioorg Med Chem. 2019. PMID: 30846405

10

Structure-based design and synthesis of pyrimidine-4,6-diamine derivatives as Janus kinase 3 inhibitors.

Yu RN, Chen CJ, Shu L, Yin Y, Wang ZJ, Zhang TT, Zhang DY. Yu RN, et al. Bioorg Med Chem. 2019 Apr 15;27(8):1646-1657. doi: 10.1016/j.bmc.2019.03.009. Epub 2019 Mar 5. Bioorg Med Chem. 2019. PMID: 30853331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,706 results

Search Page

Filters